From the Journals

Adult separation anxiety raises suicidality risk


 

Treatment target?

Commenting on the study for this news organization, Megan Rogers, PhD, postdoctoral research fellow, Mount Sinai Beth Israel, New York, said the findings “point to symptoms of separation anxiety as a potential indicator of suicidal ideation, and should these findings be replicated and extended through longitudinal research, it suggests that symptoms of separation anxiety may be a relevant treatment target in certain populations to mitigate suicide risk.”

Dr. Rogers, who is the student division director at the American Association of Suicidology and was not involved with the study, said she thinks that studies of suicide have focused more on “individual symptoms of separation anxiety, such as excessive worry about loved ones or distress when anticipating separation from loved ones, rather than on separation anxiety as a categorical diagnosis.”

However, the study has an important take-home message for practicing clinicians, Dr. Rogers said. “In individuals with separation anxiety disorders, particularly those with comorbid mood conditions, it may be worth conducting a more thorough assessment of suicide risk, given the possibility of elevated suicidality in these patients.”

The study was supported in part by the German Research Foundation and the Fondazione Cassa di Risparmio di la Spezia. The authors and Dr. Rogers have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

COVID-19: Helping patients overcome what might feel like an existential crisis
Federal Practitioner
Being in the now
Federal Practitioner
Heroes: Nurses’ sacrifice in the age of COVID-19
Federal Practitioner
Mepolizumab reduced exacerbations in patients with asthma and atopy, depression comorbidities
Federal Practitioner
The psychiatrist’s role in navigating a toxic news cycle
Federal Practitioner
How to make resident mental health care stigma free
Federal Practitioner
Fauci worries about possible post–COVID-19 ‘mental health pandemic’
Federal Practitioner
Buprenorphine for OUD may also mitigate risk with concomitant benzo, Z-drug use
Federal Practitioner
New data on worldwide mental health impact of COVID-19
Federal Practitioner
Child abuse tied to persistent inflammation in later life
Federal Practitioner